Loading…
Loading…
IEIH (iShares Evolved U.S. Innovative Healthcare ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how IEIH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IEIH and 80,000+ other tickers.
The iShares Evolved U.S. Innovative Healthcare ETF (IEIH) primarily allocates its capital to the equity securities of U.S.-based pharmaceutical and biotechnology companies. Under typical market conditions, a minimum of 80% of the fund's net assets will be invested in the common stocks of firms across various market capitalizations, including large, mid, and small-cap companies. The ETF also targets enterprises categorized within the "Innovative Healthcare Evolved Sector" — specifically, those whose financial profiles have historically aligned with conventional pharmaceutical and biotechnology businesses. It is important to note that this fund operates as a non-diversified investment vehicle.
Johnson & Johnson continued its long streak of earnings beat. It outpaced revenue estimates as well but cut its full-year guidance on a strong dollar.
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
The issuer typically closes a handful of funds during the month every year.
The pandemic-driven supply chain woes and the resultant red-hot inflation, the Russia-Ukraine war and the resultant hit to the commodity market as well as the central banks' policy tightening in the developed world may cause global growth slowdown in the coming days.
Uncertainties are playing a big role in the Wall Street due to record-high inflation, Fed policy tightening and Omicron strain of coronavirus. Still, some ETFs may warm up your winter portfolio.